Published in Biomed Res Int on October 27, 2016
The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med (2007) 7.59
Sequence- and target-independent angiogenesis suppression by siRNA via TLR3. Nature (2008) 7.10
Cre recombinase: the universal reagent for genome tailoring. Genesis (2000) 6.29
Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell (2011) 4.54
Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits. Proc Natl Acad Sci U S A (2007) 3.07
Reactive oxygen species activate the HIF-1alpha promoter via a functional NFkappaB site. Arterioscler Thromb Vasc Biol (2007) 3.02
Mouse cardiac surgery: comprehensive techniques for the generation of mouse models of human diseases and their application for genomic studies. Physiol Genomics (2004) 2.97
Genetic compensation induced by deleterious mutations but not gene knockdowns. Nature (2015) 2.40
Myocardial infarction and the open-artery hypothesis. N Engl J Med (2006) 1.46
Renalase gene polymorphisms in patients with type 2 diabetes, hypertension and stroke. Neuromolecular Med (2011) 1.20
Tissue- and cell-specific functions of the androgen receptor revealed through conditional knockout models in mice. Mol Cell Endocrinol (2011) 1.18
Renalase deficiency in heart failure model of rats--a potential mechanism underlying circulating norepinephrine accumulation. PLoS One (2011) 1.07
Renalase protects against ischemic AKI. J Am Soc Nephrol (2013) 1.05
Current status and future prospects for acute myocardial infarction therapy. Circulation (2003) 0.96
Lithium chloride suppresses colorectal cancer cell survival and proliferation through ROS/GSK-3β/NF-κB signaling pathway. Oxid Med Cell Longev (2014) 0.94
Atrial Fibrillation and Coronary Artery Disease as Risk Factors of Retinal Artery Occlusion: A Nationwide Population-Based Study. Biomed Res Int (2015) 0.86
Renalase is a novel target gene of hypoxia-inducible factor-1 in protection against cardiac ischaemia-reperfusion injury. Cardiovasc Res (2014) 0.81
Renalase and endothelial dysfunction in heart transplant recipients. Transplant Proc (2013) 0.81
Efficacy and safety of myocardial gene transfer of adenovirus, adeno-associated virus and lentivirus vectors in the mouse heart. Gene Ther (2015) 0.80
Catheter-based intramyocardial delivery (NavX) of adenovirus achieves safe and accurate gene transfer in pigs. PLoS One (2013) 0.80
Cardiospecific CD36 suppression by lentivirus-mediated RNA interference prevents cardiac hypertrophy and systolic dysfunction in high-fat-diet induced obese mice. Cardiovasc Diabetol (2015) 0.80
ECG-Based Detection of Early Myocardial Ischemia in a Computational Model: Impact of Additional Electrodes, Optimal Placement, and a New Feature for ST Deviation. Biomed Res Int (2015) 0.80
After Myocardial Ischemia-Reperfusion, miR-29a, and Let7 Could Affect Apoptosis through Regulating IGF-1. Biomed Res Int (2015) 0.80
15d-PGJ2 Reduced Microglia Activation and Alleviated Neurological Deficit of Ischemic Reperfusion in Diabetic Rat Model. Biomed Res Int (2015) 0.80
Effect of Tyrosol and Farnesol on Virulence and Antibiotic Resistance of Clinical Isolates of Pseudomonas aeruginosa. Biomed Res Int (2015) 0.78
Fuzheng Huayu Recipe Ameliorates Liver Fibrosis by Restoring Balance between Epithelial-to-Mesenchymal Transition and Mesenchymal-to-Epithelial Transition in Hepatic Stellate Cells. Biomed Res Int (2015) 0.78
Downregulation of Heparanase Expression Results in Suppression of Invasion, Migration, and Adhesion Abilities of Hepatocellular Carcinoma Cells. Biomed Res Int (2015) 0.77
The Prognosis of IVF in Poor Responders Depending on the Bologna Criteria: A Large Sample Retrospective Study from China. Biomed Res Int (2015) 0.77
Renalase as a Novel Biomarker for Evaluating the Severity of Hepatic Ischemia-Reperfusion Injury. Oxid Med Cell Longev (2016) 0.75
TES inhibits colorectal cancer progression through activation of p38. Oncotarget (2016) 0.75